News

Filter

Current filters:

Lunesta

1 to 9 of 40 results

US FDA calls for lower starting dose for sleep drug Lunesta

16-05-2014

The US Food and Drug Administration says it has required the manufacturer of the sleep drug Lunesta (eszopiclone)…

Dainippon Sumitomo PharmaLunestaNeurologicalPharmaceuticalRegulationSunovion PharmaceuticalsUSA

Eisai launches Lunesta in Japan, debuts Zebinix in France; opens Dubai office

19-04-2012

Japanese drug major Eisai (TYO: 4523) says it launched the insomnia treatment Lunesta (eszopiclone) in…

Asia-PacificEisaiEuropeLunestaMarkets & MarketingNeurologicalPharmaceuticalRest of the WorldZebinix

Eisai gets Lunesta approval in Japan, launches Fostoin

20-01-2012

Japanese drug major Eisai (TYO: 4523) this week received approval from Japan's Ministry of Health, Labor…

Asia-PacificEisaiFostoinLunestaMarkets & MarketingNeurologicalNobelpharmaPharmaceuticalRegulation

Japan’s Dainippon Sumitomo makes $2.6 billion bid for Sepracor

03-09-2009

In yet another Japanese bid to extend its reach into the all important US pharmaceutical market, …

Asia-PacificDainippon Sumitomo PharmaEszopicloneLunestaNeurologicalNorth AmericaPharmaceutical

1 to 9 of 40 results

COMPANY SPOTLIGHT

Menarini

Back to top